In this episode of the new fortnightly series, the MS Boost, we discuss a new subcutaneous delivery mode for Tysabri, with MS nurse Louise Rath and the things you need to consider when making a switch, including the practical considerations, efficacy, logistics to costs and potential side effects.

Check out a copy of the transcript here.

With thanks to Louise Rath, MS Nurse

Louise Rath is the MS neuroimmunology nurse consultant at Alfred Health in Melbourne, Victoria. She has over 20 years’ experience in public neurology services including outpatient appointments. Louise is the nurse clinical lead at the Alfred Multiple Sclerosis & Neuroimmunology Clinic focusing on patient experience, promoting engagement in health care and developing health literacy documents for the service with consumers.

For more information about medications, call MS Plus Connect to speak with an MS Nurse Advisor.

Reach out for support:
MS Plus Connect 1800 042 138 or email [email protected]

Get in touch to share your comments and suggestions about this episode, or for future guests and episode topics by emailing [email protected] 

Views expressed on the MS Podcast, including any discussions or reference to medications or treatments by podcast guests, do not necessarily represent the views of MS Plus and should not be seen as either an endorsement or rejection of a treatment.  

MS Plus does not recommend any specific treatment for people living with MS. Decisions about any treatments, taking into consideration the potential benefits and side effects for each individual’s circumstances, should be made in careful consultation with the person’s neurologist or health care professional.